
$145M+
91.0%
No IPO before September 2026
15.0%
<$85M
7.0%
$85M-$100M
7.0%
$145M+
$1,253.394
91.0%
ending in: 16hr
No IPO before September 2026
$427.45
15.0%
ending in: 16hr
<$85M
$352
7.0%
ending in: 16hr
$85M-$100M
$307
7.0%
ending in: 16hr
$100M-$115M
$312
7.0%
ending in: 16hr
$115M-$130M
$366.46
7.0%
ending in: 16hr
$130M-$145M
$366.67
7.0%
ending in: 16hr
This market will resolve based on Scribe Therapeutics' mar....